Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinase
Corinna Kosnopfel(University Hospital Münster), Birgit Schittek(University of Tübingen)
Cited by 48
Related Papers
Examination of Regional Lymph Nodes by Sentinel Node Biopsy and Molecular Analysis Provides New Staging Facilities in Primary Cutaneous Melanoma
|Journal of Investigative Dermatology|2000|183
β-Catenin Signaling Increases during Melanoma Progression and Promotes Tumor Cell Survival and Chemoresistance
|PLoS ONE|2011|108
Detection of Melanoma Micrometastasis in Sentinel Nodes by Reverse Transcription-Polymerase Chain Reaction Correlates With Tumor Thickness and Is Predictive of Micrometastatic Disease in the Lymph Node Basin
|The American Journal of Surgical Pathology|1999|82
Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness
|British Journal of Dermatology|2001|50
Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition
|Cell Death and Disease|2020|29